Graves’ disease is an autoimmune condition that causes the thyroid to become overactive (hyperthyroidism), leading to symptoms like weight loss, rapid heartbeat, and anxiety.
Graves' Disease
Graves' disease is an immune system condition that affects the thyroid gland, leading to the release of excessive thyroid hormone, known as hyperthyroidism. Since the thyroid hormone affects various organs in the body, Graves’ disease has similar complications. The disease is more common in women and in people above 30 years.
Finding New Potential Treatments for Adults with Graves’ Disease
Hightower Clinical will soon launch a clinical trial for adults with Graves’ disease who still experience an overactive thyroid despite taking antithyroid medications. This Phase 2b study will test a new investigational treatment to evaluate how safe and effective it is compared to a placebo.
Condition
Graves’ Disease
Current Status
Upcoming
Location
Oklahoma
Frequently Asked Questions
Who can participate in this study?
Adults with Graves’ disease who remain hyperthyroid even while on antithyroid medication may qualify for the study.
What is a placebo-controlled study? -
In a placebo-controlled study, some participants receive the investigational drug, while others receive a placebo (inactive substance) to compare results.
Unlock New Opportunities in Clinical Research - Join Today!
We're here and eager to assist. Reach out to Hightower Clinical Research in Oklahoma City, OK for further details on how we can support you.
Get Involved Today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.